This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Deep Transcranial Magnetic Stimulation (or dTMS) utilizes innovative technology that is safe to combine with any type of medication. It has been shown to offer relief from treatment-resistant depression, as well as various other mental health conditions.
A noninvasive treatment course, dTMS is not only safe and proven to alleviate mental health symptoms in combination with medication or psychotherapy, but is also effective as a standalone treatment.
Combining Deep TMS with medication has actually been found to offer greater symptom relief than medication alone. As an example, a study from 2019 published in the Journal of Psychiatric Research found that undergoing dTMS therapy while also receiving standard medication for Major Depressive Disorder (MDD) created a significantly greater level of relief than medication treatment alone.
Deep TMS is also safe when combined with treatments for obsessive-compulsive disorder (OCD). A 2019 study in the American Journal of Psychiatry confirmed this, finding that receiving dTMS treatment with antidepressants or cognitive behavioral therapy (CBT) can safely offer symptom relief to patients with OCD.
Additionally, studies have shown that when treating Posttraumatic Stress Disorder (PTSD), a multi-channeled treatment system can be beneficial beyond a singular means of support. Specifically, a combination of dTMS and psychotherapy has been found to produce better results for patients with PTSD than either dTMS or psychotherapy alone.
BrainsWay’s Deep TMS treatment can also act as a counterbalance to gradually less effective treatment options. In a groundbreaking 2006 study from The American Journal of Psychiatry that included over 4,000 participants, successive medical treatments were found to have a diminishing clinical effect on many people battling MDD symptoms. As such, adding dTMS to an existing medical treatment course could provide additional support to those who find their medication’s effect beginning to wane.
Substantive research is also being conducted on combining dTMS with psychotherapy. Though still in development, studies suggest that carrying out dTMS treatment during or in proximity to psychotherapy can also result in a greater treatment effect in general.
In the search for safe and effective treatment, BrainsWay’s Deep TMS offers relief to various mental health conditions with its groundbreaking technology. Its ability to provide a comprehensive and integrative treatment course when combined with medication and other forms of care is another way in which it is redefining the world of mental health support.